Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-029572
Filing Date
2024-03-12
Accepted
2024-03-11 20:25:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 engene-424b3_march_2024.htm 424B3 1237224
2 GRAPHIC img139204451_0.jpg GRAPHIC 14394
  Complete submission text file 0000950170-24-029572.txt   1258221
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B3 | Act: 33 | File No.: 333-275700 | Film No.: 24739903
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)